Immunic, Inc. Announces Private Placement of up to $240 Million
NEW YORK, Jan. 5, 2024 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...